{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:28:50Z","timestamp":1761596930401},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T00:00:00Z","timestamp":1128470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00296-005-0040-0","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T16:11:39Z","timestamp":1128442299000},"page":"608-613","source":"Crossref","is-referenced-by-count":42,"title":["Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Beh\u00e7et\u2019s disease. Does interleukin-1\u03b2 play a major role in Beh\u00e7et\u2019s synovitis?"],"prefix":"10.1007","volume":"26","author":[{"given":"Salih","family":"Pay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysel","family":"Pekel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Musabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Dinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,5]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B","volume":"44","author":"M Yamamura","year":"2001","unstructured":"Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H (2001) Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 44:275\u2013285","journal-title":"Arthritis Rheum"},{"issue":"Suppl27","key":"40_CR2","first-page":"S1","volume":"20","author":"CA Dinerallo","year":"2002","unstructured":"Dinerallo CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20(Suppl27):S1\u2013S13","journal-title":"Clin Exp Rheumatol"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","volume":"73","author":"JA Gracie","year":"2003","unstructured":"Gracie JA, Robertson SE, Melnnes IB (2003) Interleukin-18. J Leukoc Biol 73:213\u2013224","journal-title":"J Leukoc Biol"},{"key":"40_CR4","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","volume":"167","author":"CP Cristy","year":"2001","unstructured":"Cristy CP, Jacques CMM, Amin MA, Matthew AC (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167:1644\u20131653","journal-title":"J Immunol"},{"key":"40_CR5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/labinvest.3780351","volume":"81","author":"JC Morel","year":"2001","unstructured":"Morel JC, Park CC, Kumar P, Koch AE (2001) Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NF kappa B activation. Lab Invest 81:1371\u20131383","journal-title":"Lab Invest"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","volume":"48","author":"LA Joosten","year":"2003","unstructured":"Joosten LA, Radstake TR, Lubberts E, Van den Bersselaar LA, Van Riel PL, Van Lent PL, Barrera P, Van den Berg WB (2003) Association of interleukin-18 expression with enhanced levels of both interleukin-1 beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 48:339\u2013347","journal-title":"Arthritis Rheum"},{"key":"40_CR7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.4049\/jimmunol.167.5.2879","volume":"167","author":"BP Leung","year":"2001","unstructured":"Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, Cunha F, Liew FY, McInnes IB (2001) A role for IL-18 in neutrophil activation. J Immunol 167:2879\u20132886","journal-title":"J Immunol"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Ann Rev Immunol 19:423\u2013474","journal-title":"Ann Rev Immunol"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2249.2004.02475.x","volume":"136","author":"JA Gracie","year":"2004","unstructured":"Gracie JA (2004) Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 136:402\u2013404","journal-title":"Clin Exp Immunol"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455\u2013461","journal-title":"Ann Rheum Dis"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/39.12.1357","volume":"39","author":"C Ribbens","year":"2000","unstructured":"Ribbens C, Andre B, Kaye O, Kaiser MJ, Bonnet V, Jaspar JM, de Groote D, Franchimont N, Malaise MG (2000) Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology 39:1357\u20131365","journal-title":"Rheumatology"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","volume":"61","author":"C Ribbens","year":"2002","unstructured":"Ribbens C, Porras MM, Fanchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61:161\u2013166","journal-title":"Ann Rheum Dis"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/ard.62.11.1094","volume":"62","author":"I Tchetverikov","year":"2003","unstructured":"Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TWJ, Hanemaaijer R (2003) Matrix metalloproteinases-3,-8,-9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 62:1094\u20131099","journal-title":"Ann Rheum Dis"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.10547","volume":"46","author":"K Masuhara","year":"2002","unstructured":"Masuhara K, Nakai T, Yamaguchi K, Yamasaki S, Sasaguri Y (2002) Significant increases in serum and plasma concentrations of matrix metalloproteinases-3 and 9 in patients with rapidly destructive osteoarthritis of the hip. Arthritis Rheum 46:2625\u20132631","journal-title":"Arthritis Rheum"},{"key":"40_CR15","first-page":"826","volume":"29","author":"M Gattorno","year":"2002","unstructured":"Gattorno M, Vignola S, Falcini F, Sabatini F, Buoncompagni A, Simonini G, Picco P, Pistoia V (2002) Serum and synovial fluid concentrations of matrix metalloproteinases-3 and its tissue inhibitor 1 in juvenile idiopathic arthritides. J Rheumatol 29:826\u2013831","journal-title":"J Rheumatol"},{"key":"40_CR16","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.1780330808","volume":"33","author":"LH Calabrese","year":"1990","unstructured":"Calabrese LH, Michel BA, Bloch DA (1990) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 33:1108\u20131113","journal-title":"Arthritis Rheum"},{"key":"40_CR18","first-page":"10","volume":"18","author":"RD Altman","year":"1991","unstructured":"Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18:10\u201312","journal-title":"J Rheumatol"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/art.20064","volume":"50","author":"SM Dai","year":"2004","unstructured":"Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K (2004) Interleukin-18 enhances monocyte tumor necrosis factor alpha and, interleukin-1 beta production induced by contact with T Iymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 50:432\u2013443","journal-title":"Arthritis Rheum"},{"issue":"Suppl1","key":"40_CR20","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00002371-200203001-00009","volume":"25","author":"H Futani","year":"2002","unstructured":"Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, Nakanishi K, Tateishi H, Maruo S, Okamura H (2002) Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 25(Suppl1):S61\u2013S64","journal-title":"J Immunother"},{"key":"40_CR21","doi-asserted-by":"crossref","unstructured":"Morel JC, Park CC, Woods JM, Koch AE (2001) A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem 276:37069\u201337075, Epub","DOI":"10.1074\/jbc.M103574200"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.62.7.635","volume":"62","author":"TJ Smeets","year":"2003","unstructured":"Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP (2003) Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 62:635\u2013638","journal-title":"Ann Rheum Dis"},{"key":"40_CR23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s100670050004","volume":"19","author":"Y Kageyama","year":"2000","unstructured":"Kageyama Y, Miyamoto S, Ozeki T, Hiyohsi M, Suzuki M, Nagano A (2000) Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides. Clin Rheumatol 19:14\u201320","journal-title":"Clin Rheumatol"},{"key":"40_CR24","first-page":"1","volume":"37","author":"H Gotoh","year":"1997","unstructured":"Gotoh H, Obata K, Yamada H, Yoshihara Y, Kikuchi Y, Shinmei M (1997) Levels of matrix metalloproteinases-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Ryumachi 37:1\u20138","journal-title":"Ryumachi"},{"key":"40_CR25","first-page":"1599","volume":"23","author":"N Ishiguro","year":"1996","unstructured":"Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H (1996) Determination of stromelysin-1, 72 and 92\u00a0kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 23:1599\u20131604","journal-title":"J Rheumatol"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02249017","volume":"13","author":"S Sasaki","year":"1994","unstructured":"Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T (1994) Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 13:228\u2013233","journal-title":"Clin Rheumatol"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/rheumatology\/41.5.484","volume":"41","author":"AI Catrina","year":"2002","unstructured":"Catrina AI, Lampa J, Ernestam S, Klint E, Bratt J, Klareskog L, Ulfgren AK (2002) Anti-tumour necrosis factor (TNF)-therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology 41:484\u2013489","journal-title":"Rheumatology"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/ard.62.5.440","volume":"62","author":"O Elkayam","year":"2003","unstructured":"Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M (2003) Active leflunomide metabolite inhibits interleukin 1, tumour necrosis factor, nitrite oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis 62:440\u2013443","journal-title":"Ann Rheum Dis"},{"key":"40_CR29","first-page":"238","volume":"31","author":"PA Klimiuk","year":"2004","unstructured":"Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J (2004) Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. J Rheumatol 31:238\u2013242","journal-title":"J Rheumatol"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s100670200125","volume":"21","author":"S Pay","year":"2002","unstructured":"Pay S, Erdem H, Serdar M, Dine A, Simsek I, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behcet\u2019s disease and familial Mediterranean fever? Clin Rheumatol 21:511\u2013515","journal-title":"Clin Rheumatol"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoul","year":"2002","unstructured":"Hamzaoul K, Hamzaoul A, Guemira F, Bessioul M, Hamza M, Ayed K (2002) Cytokine profile in Beh\u00e7et\u2019s disease patients. Scand J Rheumatol 31:205\u2013210","journal-title":"Scand J Rheumatol"},{"issue":"Suppl30","key":"40_CR32","first-page":"S8","volume":"21","author":"A Hamzaoui","year":"2003","unstructured":"Hamzaoui A, Ghrairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-8 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behcet\u2019s disease. Clin Exp Rheumatology 21(Suppl30):S8\u2013S14","journal-title":"Clin Exp Rheumatology"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.2003.013243","volume":"63","author":"I Tchetverikov","year":"2004","unstructured":"Tchetverikov I, Ronday HK, van El B, Kiers GH, Verzijl N, TeKoppele JM, Huizinga TWJ, DeGroot J, Hanemaaijer R (2004) MMP profile in paired serum and synovial fluid samples of patient with rheumatoid arthritis. Ann Rheum Dis 63:881\u2013883","journal-title":"Ann Rheum Dis"},{"key":"40_CR34","doi-asserted-by":"crossref","unstructured":"Erdem H, Pay S, Serdar M, \u015eim\u015fek \u0130, Din\u00e7 A, Pekel A, Mu\u015fabak U, Turan M (2004). Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Beh\u00e7et\u2019s disease, familial Mediterranean fever, rheumatoid arthritis and osteoarthritis. Rheum Int (in press)","DOI":"10.1007\/s00296-004-0524-3"},{"issue":"Suppl24","key":"40_CR35","first-page":"S37","volume":"19","author":"I Ertenli","year":"2001","unstructured":"Ertenli I, Kiraz S, Calg\u00fcneri M, Celik I, Erman M, Haznedaroglu IC, Kirazl\u0131 S (2001) Synovial fluid cytokine levels in Behcet\u2019s disease. Clin Exp Rheumatol 19(Suppl24):S37\u2013S41","journal-title":"Clin Exp Rheumatol"},{"key":"40_CR36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","volume":"42","author":"J Karasneh","year":"2003","unstructured":"Karasneh J, Hajeer AH, Barrett J, Ollier WER, Thornhill M, G\u00fcl A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increase susceptibility for Beh\u00e7et\u2019s disease. Rheumatolgy 42:860\u2013864","journal-title":"Rheumatolgy"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0040-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0040-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0040-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T22:49:46Z","timestamp":1683240586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0040-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,5]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0040-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,5]]}}}